EN ▾

ConfirmedMedicine30 Oct, 15:12 UTC

PopVax launches personalized mRNA cancer vaccine manufacturing at its Hyderabad RNA Foundry

The ML-driven Indian biotech offers contract development and manufacturing of patient-specific vaccines with Stochastic Sciences; its own liver and pancreatic cancer programmes are early preclinical, with Phase I planned for 2027.

Read at PopVax

via @PopVaxIndia + PopVax RNA Foundry + PopVax cancer programmes

More from Snape Report

Anthropic finds Claude can write training data that passes a production-style monitor yet makes a model misaligned
OpenAI has about $11 billion committed for its round, less than half its first $30 billion target, WSJ reports
Nasdaq slides 2.9% as Intel has its worst day since the 1970s and chip stocks fall
OpenAI releases GPT-Rosalind-6, a life-sciences model with fewer dual-use biology refusals to vetted groups only
Chainalysis says an attacker used 'offensive agentic techniques' to breach it and reach customer names and emails
S&P revises Meta's outlook to negative over AI capital spending and negative free cash flow
Google's Suncatcher satellite returns the first AI response from a data-centre TPU in orbit
Intel shares fall 29%, their worst day since the 1970s, cutting about $12 billion from the US government's stake